Showing results (1681-1690 of 1,881) with videos related to
Sort By:
Pageof 189
Immunotherapy|November 26, 2020
Prognosticating role of serum eosinophils on immunotherapy efficacy in patients with advanced melanomaAdi Kartolo, Ryan Holstead, Wilma Hopman, et al.Immunotherapy|November 26, 2020
HLA loss of heterozygosity-mediated discordant responses to immune checkpoint blockade in squamous cell lung cancer with renal metastasisSheng Yu, Zhikun Zhao, Longyun Chen, et al.Immunotherapy|December 23, 2020
First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in PolandBożena Cybulska-Stopa, Renata Pacholczak-Madej, Grażyna Kamińska-Winciorek, et al.Immunotherapy|March 16, 2021
Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancersBabar Bashir, John C Flickinger, Adam E SnookImmunotherapy|November 17, 2021
Pembrolizumab-induced follicular eruption and response to isotretinoinCathal O'Connor, Derek Power, Catherine Gleeson, et al.Immunotherapy|November 9, 2021
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: a systematic reviewErnesto Rossi, Giovanni Schinzari, Brigida Anna Maiorano, et al.Immunotherapy|November 24, 2021
Autologous enzyme-linked immunosorbent facilitated antigen binding detects IgE-blocking activity based on direct competition between allergen-specific IgE and non-IgEHaifeng Zhong, Xuxin Lai, Jing Li, et al.Immunotherapy|November 8, 2021
Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseasesUlrich Baumann, Maria Fasshauer, Christine Pausch, et al.Immunotherapy|November 8, 2021
Alemtuzumab-induced red cell aplasia and other immune cytopenias: not so 'pure'Lucy Aitken, Ronak Patel, James D'Rozario, et al.Immunotherapy|December 6, 2021
Treatment and overall survival among anti-PD-1-exposed advanced melanoma patients with evidence of disease progressionCathy A Pinto, Xinyue Liu, Xiaoyun Li, et al.Pageof 189